Efficacy of Ciprofloxacin Therapy in Avoidance of Sepsis in Patient Undergoing Percutanous Nephrolithotomy

• Status: Recruiting
• Trial end date: 2022-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Efficacy of ciprofloxacin therapy in avoidance of sepsis in patient undergoing percutanous nephrolithotomy. A randomized controlled trial.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Diaa Eldin Taha Ramadan Mohamed
• Treatments: Ciprofloxacin; Levofloxacin; Ofloxacin

Criteria

Inclusion Criteria:

• 1. Patient 18 years or older

• Stones ≥ 2 cm and/or mild to moderate hydronephrosis

• Sterile mid urine stream

Exclusion Criteria:

• Patients with a stent, nephrostomy tube or indwelling catheter

• Renal failure

• Fever before surgery

• Previous manipulation/procedure

• Concomitant bladder stone or tumour

• Patients with active UTI

• Contralateral renal/ureteric stone